Search
for
Sort by
Research 61–90 of 1000+
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- RỤNG TÓC VÀ SỨC KHỎE TÂM THẦN: MỐI LIÊN HỆ HAI CHIỀU VỚI LO ÂU, MẤT NGỦ VÀ CHẤT LƯỢNG CUỘC SỐNG
- withdrawn
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Effectiveness of Abrocitinib in Adolescent Alopecia Areata: A Prospective Observational Pilot Study
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata
- Baricitinib regrows hair in adolescents with alopecia areata
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Efficacy and Safety of Intralesional Triamcinolone Acetonide Injection in The Treatment of Alopecia Areata
- Clinicoepidemiological profile, precipitating factors and severity indicators in alopecia areata in Manipur
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Management of acne
- 344 Topical carbamide peroxide for treatment of mild to moderate acne vulgaris
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Comparison of the Efficacy of 5% Dapsone Gel and 1% Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement